Sonoscape

Sonoscape (SonoScape Medical Corp.; Chinese: 开立医疗) is a Chinese medical imaging and medical device company headquartered in Shenzhen, Guangdong. It develops, manufactures and sells diagnostic imaging equipment and related clinical solutions, with a product portfolio centered on ultrasound systems and endoscopy devices. The company is publicly listed on the Shenzhen Stock Exchange's ChiNext board under the ticker 300633. Sonoscape operates in the medical imaging and medtech segment, competing in a global market historically dominated by large multinational imaging vendors. Its offerings span ultrasound platforms used in radiology, cardiology, obstetrics and gynecology, and point-of-care settings, as well as flexible endoscopy systems for gastrointestinal and other clinical applications. The company markets its products both in China and internationally, serving hospitals, clinics and healthcare providers across multiple regions. As a Chinese medtech manufacturer, Sonoscape is part of a broader wave of domestic medical device companies that have expanded from the home market into overseas sales, supported by cost-competitive engineering and an increasing focus on higher-end imaging performance. Its brand is associated with accessible diagnostic imaging and endoscopy equipment for a wide range of clinical users. The company's official website is sonoscape.com. Detailed corporate history, ownership structure and financial specifics are not fully captured in the available evidence and should be verified against primary sources.

Sonoscape (SonoScape Medical Corp.; 开立医疗) is a Chinese medical imaging and medical device company headquartered in Shenzhen, Guangdong. It was founded in 2002 and grew within China's emerging domestic medtech sector, focusing on diagnostic imaging equipment. The company's core business developed around ultrasound imaging systems, which it manufactures and sells to hospitals, clinics and other healthcare providers. Over time, Sonoscape expanded its portfolio beyond ultrasound into endoscopy, adding flexible endoscopy systems for clinical applications such as gastrointestinal examination. This dual focus on ultrasound and endoscopy positioned the company within the broader medical imaging and medtech device market, where it competes with both international imaging vendors and other Chinese manufacturers. The company became publicly listed on the Shenzhen Stock Exchange's ChiNext board under the ticker 300633, giving it access to capital markets to support research, development and international expansion. Sonoscape markets its products both in China and overseas, serving customers across multiple regions including Europe, Asia-Pacific and other international markets. As part of the wave of Chinese medical device companies moving up the value chain, Sonoscape has emphasized product development and broader global distribution. Detailed dated milestones, ownership changes and financial results are not fully documented in the available evidence and should be confirmed with primary sources such as company filings and the official website.

• 2002

  Sonoscape founded in Shenzhen, China.

• Listed on the Shenzhen Stock Exchange ChiNext board under ticker 300633.

• Ultrasound imaging systems

• Flexible endoscopy systems

1. 1Sonoscape official websitesonoscape.com